Abstract Diseases affecting endodermal organs like the pancreas, lung, and gastrointestinal tract have a substantial impact on human welfare. Since many of these are congenital defects that arise as a result of defects during development, broad efforts are focused on understanding the development of these organs so as to better identify risk factors, disease mechanisms, and therapeutic targets. Studies implementing model systems, like the amphibian Xenopus, have contributed immensely to our understanding of signaling pathways (e.g., Wnt, FGF, BMP, RA) and gene regulation (e.g., hhex, ptf1a, ngn3) that underlie normal development as well as disease progression. Recent advances in genome engineering further enhance the capabilities of the Xenopus model system for pursuing biomedical research, and will undoubtedly result in a boom of new information underlying disease mechanisms ultimately leading to advancements in diagnosis and therapy.
Introduction
The pancreas and gastrointestinal (GI) tract are components of the digestive system, and are responsible for a number of physiological functions, including the breakdown of food for nutrient release, absorption of water, ions, minerals and nutrients, glucose homeostasis, and hormone regulation. Dysfunction arising from cells, tissues, or systems within the digestive tract can result in a range of human diseases or syndromes affecting any of the physiological functions previously mentioned. Diseases like diabetes are of massive importance to human health and have a huge economic impact (estimated at $245 billion by the Centers for Disease Control and Prevention in 2012) resulting from the cost of therapies and lost productivity from patients suffering from direct and indirect consequences of impaired glucose homeostasis, such as heart disease and blindness [1] . Many of these GI disorders are congenital defects that arise as a result of aberrant development. The precise molecular mechanisms underlying the onset or progression of GI disorders is of great importance for the development of therapies and early diagnosis, and the amphibian Xenopus offers numerous advantages for elucidating the molecular signals controlling how the GI tract and associated organs are specified during embryogenesis [2] .
Single-cell Xenopus eggs or embryos are large (*1.2 mm X. laevis, 0.75 mm X. tropicalis), making microinjection and other mechanical manipulations relatively simple. Xenopus are non-seasonal breeders, allowing for induction of ovulation every 3 months by injection of human chorionic gonadotrophin hormone into mature females. A typical brood size obtained from a single female may reach several thousands of eggs that can be fertilized in vitro using homogenized male testicle as a sperm source; in vitro fertilization is particularly advantageous for studies that benefit from synchronously developing embryos. Xenopus embryos develop rapidly providing a tractable time frame for studying early development and organogenesis. There are two commonly used Xenopus species in research, X. tropicalis (diploid) and X. laevis (allotetraploid), and sequencing of both genomes has been completed, revealing large regions of synteny with mammals including humans [3] [4] [5] . Xenopus not only provides a remarkably broad experimental platform, but as an amphibian it also bridges the gap between costly mammalian models and the evolutionarily more distant zebrafish model [6, 7] .
The GI tract and associated organs develop from the endodermal germ layer, which in Xenopus is derived from the vegetal hemisphere of the developing embryo. Fate map studies have provided the necessary information to enable targeted manipulation of specific regions and organs in the developing endoderm [8, 9] . Xenopus embryos and tadpoles represent an excellent source for endodermderived organs, and precursor tissues for molecular analysis [10, 11 •• , 12, 13] . Aided by an expansive collection of expression data (e.g., in situ hybridization, microarray, RNA-seq) available to the community via the Xenopus website ''Xenbase'' (www.xenbase.org) [14] [15] [16] , and the release of genome wide stage specific transcriptomic datasets in addition to parallel proteomic expression data [17] [18] [19] [20] , provide substantial resources that can help shape hypotheses directed at understanding the mechanisms of development and disease.
Foregut Specification
Many congenital malformations of the GI tract are a direct result of abnormal development during embryogenesis. Deciphering the molecular mechanisms that control how endodermal organs are specified during early development is helpful in understanding how these anomalies arise, and Xenopus provides unparalleled access for embryological manipulations at these early stages. The foregut arises from the anterior endoderm and gives rise to many different organs, including the liver, pancreas, duodenum, and lungs [21] . Several recent studies have used Xenopus to decipher the molecular mechanisms controlling how these organs become subdivided in the early endoderm and identified interactions between the Wnt and BMP pathways. Microinjections into different Xenopus blastomeres at early cleavage stages allows for accurate targeting of specific molecules to distinct regions of the developing GI tract that can be combined with transplantations and explants of these regions to ascertain the effects in different conditions [22] .
Using these approaches, several reports showed that Wnt signaling activity must be excluded from the anterior endoderm to allow for proper formation of liver and pancreas [13, 23, 24 • , 25] . The Zorn lab used elegant transplantations of anterior and posterior endoderm combined with overexpression of key Wnt components to show that Wnt signaling must be repressed during the initial stages of foregut development (Fig. 1a) . In addition, they were able to control the timing of activation using hormone-inducible proteins, and this allowed them to identify a narrow time window when Wnt must be inhibited, from the end of gastrulation at stage 11 to mid-neurula stage 15 [23] . This led them to identify the hhex gene as the mediator of foregut specification, and through promoter analysis they identified the transcription factor Vent2 as the key repressor of hhex expression in the posterior endoderm [23] . In agreement with this, the RNA-binding protein Staufen 2 was recently shown to be necessary for hhex expression in the anterior endoderm, and its loss led to ectopic expression of vent2 in the anterior endoderm [26] . Subsequent studies revealed that Wnt signaling was suppressed by the secreted Wnt antagonist Sfrp5 [25] . These studies led to a model where Wnt signaling regulated hindgut development, while suppression of Wnt promoted foregut development.
However, a recent study revealed that low levels of Wnt signaling are actually required for foregut development [27] . In that study, they were able to create multiple thresholds of Wnt signaling using a combination of fzd7 knockdown (to eliminate Wnt signaling) with different doses of the small molecule BIO, which inhibits GSK3 thereby promoting Wnt signaling. They found that complete elimination of Wnt signaling in the anterior endoderm by fzd7 morpholino inhibited foregut development, while treatment with low levels of BIO in the fzd7 morphants led to restoration of hhex expression [27] . More recently, BMP signaling was also found to play an important role in the process. By comparing the gene expression profiles of anterior endoderm explants, either alone or with mesoderm, BMP signaling from the mesoderm was found to be required at these early stages to maintain foregut progenitors [28 •• ] . They found that Sizzled (Szl) was induced in the endoderm by mesodermal BMP signals and that loss of szl resulted in agenesis of liver, thyroid, pancreas, and lung. These studies point to the importance of Wnt and BMP signaling for proper development of foregut organs.
In parallel, retinoic acid (RA) signaling has been shown to promote development of foregut organs. A recent study by the Chen lab identified a direct RA target gene, N-myc downstream regulated gene 1a (ndrg1a), as being required for proper specification of the pancreas, esophagus, stomach, and duodenum [24 • ]. They showed that ndrg1 was expressed in the dorsal anterior endoderm and that it acted to repress Wnt signaling. Using TALEN-mediated genome editing, they demonstrated that mutations in ndrg1 resulted in pancreas, stomach, and duodenum hypoplasia, with no effect on the liver; a similar phenotype was found in the morpholino knockdown embryos as well. These results provide a link between RA signaling and Wnt repression in the anterior endoderm and provide mechanistic insight into how the foregut is patterned.
Epithelial Morphogenesis
Not only is Xenopus useful for studying patterning and cell fate specification, but also it provides a useful model to study morphogenesis of the developing gut. In the last few years, several groups have identified key components of signaling pathways required to establish and maintain proper GI epithelium [25, 28 •• , 29, 30 • ]. Two of these studies linked Wnt and BMP patterning events to tissue morphogenesis [25, 28 •• ]. In the first study, they showed that sfrp5 was required to establish proper foregut epithelium and they were able to identify that both canonical and noncanonical Wnt signaling was critical for specification and morphogenesis, respectively. As Sfrp5 inhibits Wnt ligands, it is able to interfere with both canonical and noncanonical Wnt pathways. Since knockdown of sfrp5 resulted in defects in both patterning and morphogenesis of the foregut, the Zorn lab was able to identify whether each or both defects was due to perturbations of the canonical or noncanonical Wnt pathway. They showed that epithelial integrity (and not patterning defects) was restored in sfrp5 morphants by blocking noncanonical Wnt signaling with mutant Dsh constructs or using a JNK inhibitor. Conversely, patterning defects, but not epithelial integrity, were restored in sfrp5 morphants by blocking the canonical Wnt pathway using Dkk1 or mutant Dsh constructs. They went on to show that Wnt11 was the target of Sfrp5 for both pathways [25] , while a more recent study showed that Wnt5 was a target for the noncanonical Wnt pathway [31] .
A recent publication from the Nascone-Yoder lab further extended the results and showed that JNK activity controlled the rearrangement of endodermal cells underlying elongation of the gut tube in Xenopus [30 • ]. They found that JNK activity maintained cell-cell adhesion by stabilizing microtubules necessary for gut tube elongation and they confirmed that JNK was not required for patterning the digestive tract. Similarly, shroom3, a known regulator of epithelial morphogenesis in the neural tube, was identified as a key regulator of epithelial morphogenesis in the developing Xenopus gut [29] . In that paper, they demonstrated another strength of Xenopus to find a Pitx1 enhancer element in the shroom3 promoter and show that both pitx1 and shroom3 were required for epithelial cell shape changes. These results demonstrate the strength of using Xenopus to interrogate signaling pathways responsible for patterning and morphogenesis of the developing GI tract. 
Pancreas Development
The pancreas is an endodermaly derived organ that initially develops from a single dorsal bud and two ventral buds, which by 3 days post-fertilization in Xenopus embryos, fuse together to form a single pancreas [32] . This differs from mammals, where one of the ventral bud regresses before fusion at E12.5 in mice [33] and 6 weeks of fetal development in humans [34] . Developmental defects occurring at these early stages of pancreas formation can lead to clinically recognizable anomalies, including annular pancreas or pancreas divisum that result from inappropriate ventral pancreas formation and dorsal pancreas agenesis [35] .
Xenopus provides an excellent model in which to study development of dorsal and ventral pancreatic buds and identify the molecular genetic differences between them. For example, by producing chimeric embryos where either the dorsal or ventral pancreatic bud was labeled, we demonstrated that the ventral pancreatic bud cells migrate extensively into the dorsal bud after fusion while dorsal pancreatic bud cells do not (Fig. 1b) [11 •• ] . By isolating individual dorsal and ventral pancreatic buds, we compared their gene expression profiles and identified several new genes involved in regulating cell fate specification and proliferation in the developing pancreas [11 •• , 36, 37] . We showed that the tetraspanin tm4sf3 was localized to the ventral pancreas and regulated fusion of the dorsal and ventral buds [11 •• ] , whereas the RNA-binding protein Celf3 controls proliferation in the developing endoderm through translational activation of key cell cycle genes. By producing different fusion proteins between Celf3 and Celf1, we identified the linker region of Celf3 as responsible for the translational enhancement activity on cyclin A2 mRNA [36] . More recently, it was shown that the transcription factor Hhex plays a critical role in regulating formation of the ventral pancreatic bud, but does not influence dorsal pancreas formation [38] . These results demonstrate the utility of Xenopus for rapid identification and functional analysis of new genes involved in regulating development of the dorsal and ventral pancreatic buds.
Xenopus is also a useful platform for investigating the temporal activity of pancreatic transcription factors in controlling specification of individual cell fates. A recent study revealed that transient expression of the pancreatic endocrine transcription factor Ngn3 (using a hormone-inducible version) for 1-4 h during early neurula stages promoted development of beta and delta cells and not alpha cells, while similar transient expression at mid-neurula stages promoted development of alpha, beta, and delta cells [39 • ]. The authors then went on to isolate endodermal tissue 4 h after Ngn3 activation and identified many new downstream targets of Ngn3; using morpholinos to block translation they showed that several of these new factors were essential for endocrine pancreatic cell development downstream of Ngn3. Other studies in Xenopus have also demonstrated the sufficiency of specific pancreatic transcription factors (Pdx1 and Ptf1a) to promote ectopic pancreatic fates either in the early endoderm or through transdifferentiation of liver to pancreas [12, [40] [41] [42] . Moving forward, Xenopus provides an excellent platform to define the pancreatic gene regulatory network and can be used to interrogate these relationships in high temporal resolution. The ability to combine gain-of-function and loss-of-function techniques in developing endoderm highlight the benefits that Xenopus can offer for elucidating the molecular mechanisms controlling pancreatic cell fate specification.
Diabetes
Xenopus has also proven useful in elucidating the function of candidate genes related to diabetes and establishing the significance of specific gene mutations identified in humans. Neonatal diabetes is a form of diabetes that affects infants in their 1st year of life. Mitchell-Riley syndrome (MRS) is a neonatal diabetes syndrome that presents with hypoplastic pancreas and gall bladder, and intestinal atresia [43, 44] . MRS has been linked to several distinct mutations in the gene encoding the transcription factor, Regulatory Factor X 6 (Rfx6) [45] ; these studies, however, did not address whether these specific point mutations altered Rfx6 function. Studies in Xenopus were performed to establish whether these specific mutations altered Rfx6 function, interfering with proper pancreas development and thus could contribute to the development of neonatal diabetes [46] . First, they established that knockdown of Rfx6 using antisense morpholinos to block translation of rfx6 mRNA resulted in pancreatic and endodermal defects, showing that Rfx6 functioned similarly in Xenopus. Next, they showed that co-injection of mRNA encoding a wild-type Rfx6 rescued these specific defects thus identifying an assay to test the function of mutant rfx6 versions. Last, they generated three different mutant versions of rfx6 that reproduced the human mutations found in patients and tested their ability to rescue the Rfx6 knockdown phenotype; two of these were single point mutations that changed one amino acid. They found that none of these mutant versions were able to rescue the Rfx6 knockdown phenotype like the wild-type Rfx6. This important result provided direct evidence that these specific point mutations functionally impaired Rfx6 pointing to a molecular mechanism responsible for the disease demonstrating how Xenopus can be used to directly establish whether specific mutations identified in patients is causative to the disease.
Defects in the pancreatic beta cell ATP-sensitive K? (KATP) channel (Kir6.2/SUR1) have been associated with both neonatal diabetes and type 2 diabetes [47, 48] . The KATP channels are multimeric complexes comprised of four potassium channel Kir6.2 subunits (encoded by the KCNJ11 gene) that form the inner channel and four sulfonylurea receptor 1 (SUR1) subunits (encoded by the ABCC8 gene) [47] . This hetero-octameric protein complex plays an important role in regulating insulin secretion. The KATP channels on the beta cell membrane are open in a state of low glucose; as blood glucose levels increase, glucose enters the beta cell and is subsequently metabolized leading to an increase in intracellular ATP. The increase in ATP triggers closure of the KATP channels and activation of voltage sensitive calcium channels leading to calcium-mediated insulin secretion. Loss-of-function mutations in either subunit, resulting in channel closure, leads to an increase in insulin secretion and subsequent hyperinsulinism, while gain-of-function mutations result in a decrease in insulin secretion and subsequent diabetes [49] . Sulfonylurea drugs are used to treat diabetes and these drugs increase insulin secretion by binding to SUR1 leading to closure of the KATP channel [50] .
Understanding the physiological impact, specific mutations have on channel activity is a key area of research in diabetes, and Xenopus oocytes provide a good platform to investigate the function of these channel proteins in the presence or absence of single-gene mutations and/or pharmacological treatment. The X. laevis oocyte is largely transcriptionally silent; however, the oocyte maintains a pool of maternal transcripts that provide a source for protein translation [51, 52] . A single female contains thousands of oocytes that are easily isolated and can be cultured for several days. The large size of the oocyte lends itself well to physiological perturbations allowing for direct measurement of channel activity via molecular or electrophysiological assays under a range of conditions including mutant protein, chemical inhibitors, or activators [53, 54] ; exogenous channel coding mRNAs can be delivered by microinjection and the protein products are processed and trafficked to the membrane [55] .
Several recent studies used Xenopus oocytes to investigate key interactions between sulfonylurea drugs and different variants of KATP channel subunits. In one such study, they identified a novel heterozygous mutation of the Kir6.2 gene (i.e., W68R) in a patient with remitting and relapsing neonatal diabetes. To test if the W68R could be the cause of diabetes observed in the patient, the authors overexpressed wild-type SUR1 and wild-type or mutant Kir6.2 by mRNA injection in Xenopus oocytes. Using whole cell electrophysiology methods (i.e., patch-clamp single-channel recording), the authors determined that this W68R mutation, replacement of tryptophan with arginine, reduced the ATP sensitivity of the channel [56 • ]. They went on to show that the sulfonylurea compound, tolbutamide, maintained canonical channel blocking activity, despite lowered ATP-mediated inhibition on Kir6.2, suggesting that patients harboring the W68R mutation could benefit from sulfonylurea therapy [56 • ]. Another report from the same lab examined four different Kir6.2 mutations (i.e. R210C, G334D, I296L and V59M) associated with neonatal diabetes [57] . They expressed different combinations of wild-type and mutant versions in Xenopus oocytes and measured channel activity using patch-clamp single-channel recording in excised patches. During recording, patches were treated with gliclazide, another sulfonylurea drug, to block channel activity. Their results indicated that the G334D mutation rendered Kir6.2 free of any ATP-mediated inhibition, thus in the presence of sulfonylurea the channel remained active [57] . These results help to explain why patients with a G334D mutation do not respond to sulfonylurea therapy. Subsequent studies reported on the interplay between sulfonylureas and Mgnucleotides on Kir6.2/SUR1 in Xenopus oocytes. Briefly, they found that when sulfonylureas were bound to their target on SUR1 they reduced Mg-binding to SUR1 decreasing normal channel-opening activity [58] . These studies represent rigorous physiological investigations, aided by the utility of the Xenopus oocyte, to dissect the mechanistic basis for efficacy of the sulfonylurea family of anti-diabetic drugs, and sheds light on why certain monogenic mutations lend themselves well to sulfonylurea treatment while others do not.
Lung and Thyroid Development
In addition to its well-known role as a model for early patterning events and posterior foregut development, Xenopus has emerged as a good model system for studying development of the respiratory system [59, 60 •• ] . Unique among aquatic model systems, Xenopus embryos rapidly develop lungs in the first few days of embryogenesis, which at the molecular and histological level are similar to early mouse lungs [60 •• ] . Recent studies have revealed that key signaling pathways implicated in mammalian lung development such as Wnt, FGF, and BMP, are conserved in Xenopus lung development [60 •• , 61-64] . Using small molecule inhibitors and dominant negative FGFR1 constructs, two studies showed that FGF signaling was required for specification of lung tissue, but not thyroid [62, 64] . Shifley et al. also showed that both MEK and PI3K pathways downstream of FGF are essential for lung development [64] . Using an RA antagonist, RA was also shown to be necessary for lung specification, but only during the early stages [61, 62] . Interestingly, embryos treated with RA showed ectopic lung marker expression in the presumptive thyroid, suggesting that RA is a key regulatory switch controlling lung versus thyroid development.
One of the strengths of Xenopus is the ease with which epistatic relationships between signaling pathways can be tested by simple treatment of embryos with small molecules or inducible proteins at different times. Taking advantage of this, Rankin et al. showed that Wnt acts downstream of FGF signaling to induce Nkx2.1 in presumptive lung tissue [60 •• ] . They activated FGF signaling using a drug inducible FGFR1 construct and analyzed whether constitutive FGF signaling was sufficient to induce lung development in the presence of Wnt knockdown. Activation of FGF signaling on its own was sufficient to induce ectopic Nkx2.1 expression in the foregut endoderm, while it had no effect in the presence of Wnt morpholinos [61] . Similarly, they showed that the transcription factors Osr1 and Osr2 function downstream of FGF, but upstream of Wnt signaling in lung development [61] . Additionally, they found that Osr1/Osr2 function also played a role in repressing bmp4 expression in the lateral plate mesoderm, linking these three signaling pathways. They showed that Osr1/Osr2 promoted lung specification by repressing bmp4 expression in the lateral plate mesoderm thus promoting Wnt and RA signaling. Although only recently emerging as a model for lung development, Xenopus provides a unique platform for understanding the signaling network controlling specification of early lung buds.
Genome Editing and the Future of Disease Research in Xenopus
In the last 3 years, there has been an explosion of progress in the field of disease modeling primarily due to the emergence of genome editing tools that allow researchers to generate mutations in precise regions of the genome virtually at will. Two genome editing, tools that have received much attention as of lately, are transcriptional activator like effector nucleases (TALENs) and the conserved repetitive interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system [65] . In both systems, administration of the genome editing tools, usually by microinjection, result in sequence specific targeting of host genomic DNA. The TALEN and CRISPR systems are, in most cases, engineered to have nuclease activity, such that appropriate targeting of TALEN or Cas9 proteins to the locus of interest produces double strand breaks (DSB) in genomic DNA. These DSBs are then repaired in an error prone fashion by non-homologous end-joining often leading to insertions and/or deletions (INDELS) that result in coding sequences that are defective (i.e., frameshift, premature stop) [66] [67] [68] .
TALENs and the CRISPR/Cas9 system have been used in Xenopus to generate mutations with much success [69 • , 70-73] . For example, Lei and colleagues used TALENs targeting several loci including the pancreatic master regulator Ptf1a resulting in pancreatic agenesis [72] . More recently, Guo et al. provided a comprehensive report using the CRIPSR/Cas9 system for targeting a number of endoderm and pancreas specific factor, including Ptf1a, Hhex, Elastase, and Pdx1 [69 • ]. These studies highlight the usefulness in combining the Xenopus experimental platform with genome editing tools. The next level of innovation surrounding genome editing with the goal of modeling human disease is in the development of an efficient method for homology directed repair of TALEN/CRISPR-induced DSB [68] . Investigators in nearly all model systems are contributing to these efforts and several reports of success have circulated including one using Xenopus [74] . Despite these considerable successes, it is not completely clear what the effective rate for incorporation of donor genetic material is, and the efficacy for insertion into the precise locus absent from off targets (i.e. random insertions). Nonetheless, these reports show incredible promise and once methods are widely established the technique will undoubtedly revolutionize monogenic disease characterization and modeling.
One practical challenge for disease modeling in Xenopus is the breeding and maintenance of mutant animals, since most Xenopus laboratories are not equipped to raise many different lines. The National Xenopus Resource (NXR) benefits researchers from Xenopus and non-Xenopus laboratories by providing access to an expanding repertoire of Xenopus lines available for delivery or in house use [75] . The NXR facilitates disease modeling research through a multitude of services, including custom mutant lines and a research hotel service. In the custom mutant service, the NXR designs, clones, and injects the CRISPR and TALEN constructs and then grows the animals to adulthood. A research hotel service enables investigators to come to the Marine Biological Laboratory for short-term visits and utilize NXR infrastructure, animals and expertise for a wide range of Xenopus laboratory technique, including genome engineering. Investigators can utilize these tools to generate custom animal lines necessary for their own research program, while leaving the challenge of raising these animals to the NXR [75] . Resources like the NXR provide a center for rapid disease modeling in Xenopus, and a mechanism for delivering these valuable new tools to the greater research community.
Concluding Remarks
The purpose for this review is to provide the reader with an overview of recent studies and advancements for understanding human pancreas and GI disease using the Xenopus as a platform for discovery. The major take home message from this review is the diversity of research questions that can be addressed using Xenopus to address the mechanistic basis of disease in the developing GI tract. Implementation of gene editing techniques will only enhance the utility of this model for human disease modeling.
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